Brentuximab vedotin in the treatment of CD30+ PTCL | Blood | American Society of Hematology
You do not currently have access to this content.
Related Articles
Long-term outcomes of chemoimmunotherapy with obinutuzumab/chlorambucil in chronic lymphocytic leukemia
Valentin Goede, Kirsten Fischer, Sandra Robrecht, Adam Giza, Martin JS Dyer, Michael J. Eckart, Lothar Müller, Lukáš Smolej, Nadine Kutsch, Anna-Maria Fink
Atorvastatin and Myocardial Extracellular Volume Expansion During Anthracycline-Based Chemotherapy:
AbstractBackgroundIn the STOP-CA (Statins to Prevent the Cardiotoxicity From Anthracyclines) trial, atorvastatin preserved the left ventricular ejection fraction among patients with lymphoma treate…
Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes
Key PointsVenetoclax (14 days) + azacitidine regimen was well tolerated in patients with treatment-naive HR MDS, with no unexpected safety findings.The reg
Selenoprotein-mediated redox regulation shapes the cell fate of HSCs and mature lineages
Key PointsDisruption of antioxidant selenoprotein synthesis exhibited significant defects in B lymphocyte development and HSC function.Cell context and lin
OMIP‐112: 42‐Parameter (40‐Color) Spectral Flow Cytometry Panel for Comprehensive Immunophenotyping of Human Peripheral Blood Leukocytes
We optimized a 42-parameter panel for profiling human immune cells in peripheral blood, identifying over 80 immune subsets. The panel outperforms other published panels on…
BCMA-directed CAR T-cell therapy in patients with multiple myeloma and CNS involvement
Key PointsB-cell maturation antigen–directed CAR-T therapy in patients with MM and CNS involvement is feasible without excess neurotoxicity.Data support CN
Advantages of a genomic DNA-based next-generation sequencing assay for detection of mutant NPM1 measurable residual disease in AML
Key PointsDetection of mNPM1 MRD by NGS using DNA overcomes several limitations of RT-qPCR and is therefore an attractive alternative assay.The prognostic
The ADAR1-regulated cytoplasmic dsRNA-sensing pathway is a novel mechanism of lenalidomide resistance in multiple myeloma
Key PointsLenalidomide induces immunomodulating responses through the activation of dsRNA-sensing pathway.ADAR1 drives lenalidomide resistance in MM via th
α-Actinin-1 deficiency in megakaryocytes causes low platelet count, platelet dysfunction, and mitochondrial impairment
Key Pointsα-Actinin-1 deficiency in MKs is associated with low platelet count and leads to impaired platelet function and thrombosis.α-Actinin-1 is critica
Targeting senescent stemlike subpopulations in Philadelphia chromosome–like acute lymphoblastic leukemia
Key PointsOur study discovered new regulators of ruxolitinib response in Ph-like ALL, including c-MYC as a therapeutically targetable codependency.A progno